Video - Results from #10

A Step Towards Personalized Medicine: PET-PSMA Imaging in Prostate Cancer VL

Implications of PSMA PET Imaging for Prostate Cancer Presentation & Discussion - Oliver Sartor Details A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer Implications of PSMA PET Imaging for Prostate Cancer Presentation & Discussion - Oliver Sartor Independent Medical Education Initiative Supported by Progenics Pharmaceuticals, Inc. a subsidiary of Lantheus Holdings, Inc. Biographies: Presenter: A. Oliver Sartor, MD Professor of Medicine and Medical Director, Tulane Cancer Ce...
Applying Artificial Intelligence (AI) to PSMA-targeted PET Imaging Agent 18F-DCFPyL in Prostate Cancer: Lecture & Discussion- Matthew Rettig Details A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer. Applying Artificial Intelligence (AI) to PSMA-targeting PET Imaging Agent 18F-DCFPyL (PYL) in Prostate Cancer: Lecture & Discussion. - Matthew Rettig Independent Medical Education Initiative Supported by Progenics Pharmaceuticals, Inc. a subsidiary of Lantheus Holdings, Inc. Biographies: Presenter: Matthew Rettig, MD. is Pr...